Epithelial Barrier During Corneal Infection
角膜感染期间的上皮屏障
基本信息
- 批准号:6525371
- 负责人:
- 金额:$ 28.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2005-08-31
- 项目状态:已结题
- 来源:
- 关键词:CD14 molecule Pseudomonas aeruginosa bacteria infection mechanism biological signal transduction cell component structure /function confocal scanning microscopy cornea corneal epithelium enzyme activity enzyme inhibitors eye infections flow cytometry gel mobility shift assay human tissue immunofluorescence technique immunoprecipitation keratitis lipopolysaccharides mitogen activated protein kinase neutralizing antibody nuclear factor kappa beta organ culture phosphorylation swine tight junctions western blottings
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of this application is
to understand the mechanisms underlying the induction of the inflammatory
reaction and breakdown of the epithelial barrier in the cornea upon infection.
Recent data has shown that challenging human corneal epithelial (HCE) cells
with lipopolysaccharide (LPS) isolated from Pseudomonas aeruginosa (PA), a
major cause of bacterial keratitis, increases monolayer permeability and
alteration of tight junction (TJ) status. LPS and PA challenges also lead to
activation of NF-kappaB, a transcription factor activated by Toll-like receptor
4 (TLR4, the predominant LPS receptor in mammals). Furthermore, PA infection
resulted in the loss of epithelial barrier function in cultured pig corneas.
The current application will test the hypothesis that in the cornea TLRs confer
responsiveness of HCE cells to pathogens, and PA challenge-induced TLR
signaling, through activation of NF-kappaB and/or mitogen-activated protein
kinase (MAPK), contributes to infection-induced epithelial barrier breakdown.
The following studies will be carried out. (1) Alterations of barrier
properties in corneal epithelial cells upon PA infection will be assessed using
HCE cells cultured on Transwell filters as a model epitheliuin. Parameters to
be measured include transepithelial electrical resistance, and paracellular
flux, alterations in TJ proteins ZO-1 and ZO-2. (2) Signal transduction
pathway(s) that couples PA challenge to alteration of epithelial barrier
function in HCE cells will be characterized using antibodies to detect cell
surface expression of TLRs and co-receptor CD 14, and pharmacological reagents
to inhibit activation of NF-kappaB and MAPK upon HCE cell infection. (3)
Whether infection-induced epithelial responses, including barrier breakdown,
can be inhibited by modification of TLR-mediated signaling will be assessed. A
combination of transfection of TLRs and their mutants and the neutralizing
antibodies will be used to assess epithelial response to PA challenge in
Transwell model epithelium. TLR neutralizing antibodies, along with other
biological and pharmacological reagents, will also be applied to corneal organ
culture to determine if infection-induced epithelial responses and barrier
breakdown can be inhibited. An understanding of how TLRs transmit signals that
lead to epithelial responses, including modulation of barrier function, may
allow the development of therapeutic agents that prevent breakdown or enhance
recovery of barrier function during infection and, as an adjuvant therapy,
eliminate the corneal scarring and vision loss associated with bacterial
keratitis.
描述(申请人提供):此申请的长期目标是
了解炎症诱导的基础机制
感染后,角膜上上皮屏障的反应和崩溃。
最近的数据表明,挑战人角膜上皮(HCE)细胞
与从铜绿假单胞菌(PA)分离的脂多糖(LPS),A
细菌性角膜炎的主要原因,增加单层渗透性和
紧密连接(TJ)状态的改变。 LP和PA挑战也导致
NF-kappab的激活,这是一种由Toll样受体激活的转录因子
4(TLR4,哺乳动物中的主要LPS受体)。此外,PA感染
导致培养的猪角膜上上皮屏障功能的丧失。
当前的应用将检验以下假设
HCE细胞对病原体的反应性,PA挑战诱导的TLR
信号通过激活NF-kappab和/或有丝分裂原激活的蛋白
激酶(MAPK)有助于感染引起的上皮屏障崩溃。
将进行以下研究。 (1)障碍的改变
PA感染后角膜上皮细胞中的特性将使用
HCE细胞在Transwell过滤器上培养为模型上皮素。参数为
可以测量的包括旋转电阻和细胞细胞
通量,TJ蛋白ZO-1和ZO-2的改变。 (2)信号转导
将PA挑战上皮屏障的挑战的途径
HCE细胞中的功能将使用抗体来检测细胞来表征
TLR和共受体CD的表面表达和药理学试剂
在HCE细胞感染后抑制NF-kappab和MAPK的激活。 (3)
感染引起的上皮反应,包括屏障崩溃,
可以评估TLR介导的信号传导的修饰可以抑制。一个
TLR及其突变体的转染和中和的结合
抗体将用于评估对PA挑战的上皮反应
Transwell模型上皮。 TLR中和抗体以及其他
生物学和药理试剂也将应用于角膜器官
培养以确定感染引起的上皮反应和障碍是否
分解可以抑制。了解TLR如何传递信号的理解
导致上皮反应,包括屏障功能的调节,可能
允许开发防止分解或增强的治疗剂
在感染过程中恢复屏障功能,作为一种辅助治疗,
消除与细菌相关的角膜疤痕和视力丧失
角膜炎。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fu-Shin X Yu其他文献
Fu-Shin X Yu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fu-Shin X Yu', 18)}}的其他基金
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
- 批准号:
8248480 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
7923002 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
7844845 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
- 批准号:
8655872 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
7615662 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
8332413 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
- 批准号:
8840592 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
7461874 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
- 批准号:
8445213 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
相似国自然基金
一氧化氮通过CbrA/DsbR通路调控铜绿假单胞菌毒力的机制研究
- 批准号:82302577
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
琥珀酸代谢重编逆转碳青霉烯耐药铜绿假单胞菌耐药性的研究
- 批准号:32370191
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
环丙沙星胁迫下铜绿假单胞菌的耐药机制及阻控
- 批准号:82370006
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
铜绿假单胞菌双组分系统CprRS感应人体抗菌肽LL-37的毒力调控机制
- 批准号:32300160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
铜绿假单胞菌分泌蛋白PA3125通过诱导肺泡巨噬细胞PKM2甲基化修饰抑制抗原提呈的机制研究
- 批准号:82370014
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Arf6 Inhibition as Novel Treatment for Multidrug Resistance Gram Negative Infections
Arf6 抑制作为多重耐药革兰氏阴性菌感染的新疗法
- 批准号:
9089918 - 财政年份:2015
- 资助金额:
$ 28.7万 - 项目类别:
Arf6 Inhibition as Novel Treatment for Multidrug Resistance Gram Negative Infections
Arf6 抑制作为多重耐药革兰氏阴性菌感染的新疗法
- 批准号:
9488843 - 财政年份:2015
- 资助金额:
$ 28.7万 - 项目类别:
Arf6 Inhibition as Novel Treatment for Multidrug Resistance Gram Negative Infections
Arf6 抑制作为多重耐药革兰氏阴性菌感染的新疗法
- 批准号:
9755205 - 财政年份:2015
- 资助金额:
$ 28.7万 - 项目类别:
Host-Pathogen Interactions in Cystic Fibrosis
囊性纤维化中宿主与病原体的相互作用
- 批准号:
6928462 - 财政年份:2001
- 资助金额:
$ 28.7万 - 项目类别: